home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 07/18/23

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis and SEQENS will together produce Sarconeos active compound

2023-07-18 07:11:17 ET Clinical-stage biotechnology company, Biophytis SA ( NASDAQ: BPTS ) and SEQENS concluded a master agreement for the production of the active compound in Sarconeos (BIO101), Biophytis' main drug candidate developed for three indications: severe forms of Cov...
BPTS - Biophytis and SEQENS Sign a Partnership to Produce Sarconeos (BIO101) Active Compound

PARIS, FRANCE / ACCESSWIRE / July 18, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving funct...

BPTS - Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / July 10, 2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company specializing in the development of therapies aimed at slowing the degenerative processes associated wit...

BPTS - Biophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International Congress

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 19, 2023 / Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), («Biophytis» or the «company»), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerat...
BPTS - Biophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been Adopted

RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED PARIS FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 16, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), («Biophytis» or the «company»), a ...

BPTS - Biophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of June

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 5, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, inc...

BPTS - Biophytis seeks early access authorization of COVID drug Sarconeos in France

2023-05-26 07:48:57 ET Biophytis ( NASDAQ: BPTS ), via its pharmaceutical partner Intsel Chimos, filed an application for Early Access Authorization (EAA) of Sarconeos (BIO101) to treat severe forms of COVID-19 in France. The filing to the French National Authority for He...
BPTS - Biophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 26, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, incl...

BPTS - Biophytis ticks higher after presenting COVID drug data at conference

2023-05-25 06:18:30 ET Biophytis ( NASDAQ: BPTS ) stock rose ~5% premarket on Thursday after the company said that it presented positive results from a phase 2-3 trial of Sarconeos (BIO101) in severe COVID-19 at the American Thoracic Society International Conference (ATS 2023)...

BPTS - Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 25, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, incl...
Previous 10 Next 10